Picture of Medexus Pharmaceuticals logo

MDP Medexus Pharmaceuticals News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Brief: Medexus Provides Update On Ixinity Acquisition And Overall Business In COVID-19 Environment

May 22 (Reuters) - Medexus Pharmaceuticals Inc  MDP.V :
    * MEDEXUS PROVIDES AN UPDATE ON THE IXINITY® ACQUISITION AND
ITS
OVERALL BUSINESS IN THE COVID-19 ENVIRONMENT
    * MEDEXUS PHARMACEUTICALS INC - INTEGRATION OF IXINITY IS
PROGRESSING IN LINE WITH EXPECTATIONS
    * MEDEXUS PHARMACEUTICALS INC - CONTINUE TO GENERATE STEADY
GROWTH
ACROSS KEY PRODUCT LINES
    * MEDEXUS PHARMACEUTICALS - NOT AWARE OF ANY DISRUPTION TO
SUPPLY
OF ANY OF ITS PRODUCTS TO PATIENTS

Source text for Eikon:  ID:nGNX8z3dsN 
Further company coverage:  MDP.V 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Medexus Pharmaceuticals

See all news